Navigation Links
Current in Medical Technology

New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

Data Confirm Tapentadol Efficacy and Tolerability for Acute Pain Patients RARITAN, N.J., May 26 /PRNewswire-USNewswire/ -- It is estimated that up to 30 percent of all people who have surgery experience gastrointestinal side effects, such as nausea and vomiting. The use of opioid pain medicin...

Expert Insights in Acute Lymphoblastic Leukemia: Current Challenges and Future Directions

Complimentary Continuing Education Online Activity and Podcast for Nurses and Pharmacists VOORHEES, N.J., April 22 /PRNewswire/ -- Acute lymphoblastic leukemia (ALL) is a complex heterogeneous disease which, despite significant advances in the treatment of pediatric patients, is often fatal i...

Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI

Angiomax Will Remain the NSTEMI Market Share Leader Through 2017, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 25 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a therapy...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

- Tasigna front-line data demonstrating potential in newly diagnosed patients with a life-threatening type of leukemia to be featured in two oral sessions at ASH - Exjade results at ASH to show benefits for chronically transfused patients by significantly reducing toxic iron that can dama...

NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy

Data presented at annual ICAAC/IDSA meeting in Washington, D.C. WASHINGTON, Oct. 27 /PRNewswire/ -- A novel topical therapy for nail fungus, NB-002, has demonstrated a new topical approach to healing nail fungus by penetrating skin pores and diffusing through the skin that surrounds the en...

Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials

EMERYVILLE, Calif., Sept. 25 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII ) today announced that previously found excess symptomatic intracranial hemorrhage in an earlier European trial of ancrod (now Viprinex(TM)) for the treatment of acute ischemic str...

MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion

MOUNTAIN VIEW, Calif., July 16 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) announced that the positive results from a Phase 2 study evaluating the safety, tolerability and pharmacokinetics of MAP0004 in adult asthmatics were published in the July issue of Current Medic...

Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates

Cleveland Clinic Researchers Highlight the Need For More Women to Participate in Clinical Trials ORLANDO, Fla., Nov. 6 /PRNewswire-USNewswire/ -- Cleveland Clinic researchers have recently found that women remain a significant minority in cardiovascular randomized contro...

Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development

LAKE FOREST, Calif., Sept. 18 /PRNewswire/ -- Worldwide markets of approved EGFr/HEr2 inhibitors grew by 34.2% during the first half of 2007, pushing sales to more than $3.2 billion, exceeding total sales reported in 2005. Hundreds of clinical trials are ongoing, aimed at expanding indications...

Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds

-- CancerCare offers five questions to help women learn about breast cancer therapy advances -- NEW YORK, June 12, 2007 – According to a new GfK Roper Public Affairs survey sponsored by CancerCare, a national nonprofit cancer support organization, while the majority (76 percent) of women s...

Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care

NUTLEY, N.J., June 15, 2007 /PRNewswire/ -- Results of the Option (TOcilizumab Pivotal Trial in Methotrexate Inadequate respONders) trial, the first multinational Phase III study outside of Japan, showed that patients treated with Actemra (either 4mg/kg or 8mg/kg) plus methotrexate achieved a sign...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

...-looking statements that are based on management's current expectations and beliefs and are subject to a numb...acturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development. ...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

... will be using the tax benefits generated from its current year loss from continuing operations to offset a p...t adequately control their cholesterol levels with current therapies and who need new treatment options. ... $637,511 $490,998 Other current assets 10,001 27,...

Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership

...r years. The initial focus will be on pancreatic beta cell regeneration and survival, to restore beta cell function in diabetes. The program builds on current JDRF funding at GNF that has resulted in the discovery of beta cell regeneration drug targets and candidates, and allows for the inclusion of JDRF-fun...

NewCardio Announces Master Services Agreement With Dedicated Phase I

... strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based on currently available information and assumptions made by management. Although we be...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

...ucts. For more information, please visit www.labopharm.com . This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those...

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

...c. (Nasdaq: NVAX ) announced today it has manufactured a virus-like particle (VLP) vaccine candidate against the H1N1 pandemic influenza virus under current good-manufacturing practices (cGMP) at its new vaccine manufacturing facility in Rockville, MD. This milestone was accomplished in only 11 weeks afte...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

...rward-looking statements that reflect management's current views regarding the progress and potential of the ... ------------- ----------------- current assets: Cash and cash equivalents $11... 10,110 9,319 Other current assets 5,317 6,746 ...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

...-looking statements that are based on management's current expectations and beliefs and are subject to a numb...acturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development. ...

Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention

...pts from Forum discussions regarding the limits of current screening, the impact that eliminating HPV 16/18 t...ge interventions become available, modification of current screening guidelines would be premature. "...m that this paper addresses focused on identifying current problems that restrict the utility of screening wi...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

...his effect is potentially serious. You should talk to your doctor about any current or past heart problems. Because these problems could mean you're having a h...ate Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate o...

Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor

... bio-compatible components suitable for medical device applications and will enable new medical diagnostic and therapeutic markets in which the use of current video cameras is not feasible due to their size. The miniature camera's outer diameter size, which includes a special housing, is only 1.2 mm x 5 mm l...

John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden

... portion of the profits from that product to the Global Fund to finance AIDS programs in Africa, with an emphasis on the health of women and children. current partners are: American Express (U.K. only), Apple, Converse, Gap, Emporio Armani, Hallmark, Dell, Windows and Starbucks. Since its launch in the Sprin...

GAA Calls on Secretary Clinton to Speak Out Against Gender-Based Violence During Her Africa Trip

...st Women Act (IVAWA) in the last session of Congress, and she is thus well aware that gender-based violence occurs even in countries where there is no current conflict or war. Her trip is an opportunity to highlight the need for the U.S. government to coordinate all of its programs to address VAW and VAC, a...

British Woman Celebrates a Year of Living Cancer-Free

...ssess toxicity as the main end point, efficacy being a secondary one. It is very important for us to be able to recruit more patients and complete the current phase before moving to a multicenter international study demonstrating favorable clinical outcome." Readers who would like to learn more about ...

Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk

...erapeutic Resource Center(R) in Willingboro , N.J. Willingboro, New Jersey is home to the world's largest automated pharmacy and is the current site of the Medco Therapeutic Resource Center (TRC) for oncology patients. Medco's TRCs focus on the specialized treatment of patients with chronic an...

Is Your Hair Taking a Break?

...f dermatology at Wake Forest University School of Medicine in Winston-Salem, N.C., discussed the different types of hair loss women experience and the current treatment options. "Hair loss is a very misunderstood condition, both in terms of how people see their own hair loss and how physicians who ar...

Diabetes Gene Raises Odds of Lower Birth Weight

...udies by European diabetes researchers, said Grant, had suggested that CDKAL1 was implicated in both lower birth weight and type 2 diabetes, and the current study, using a large sample size, reinforced that association. Under the fetal insulin hypothesis, a slight underproduction of insulin, an impo...

European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK

... this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors (including those specified...

Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease

...evealed that one-out-of-five women with postmenopausal osteoporosis (PMO) are retiring later than anticipated and nearly half (48 percent) blame the current economy. Despite the need to work longer, half of the women with PMO are fearful that the disease will limit their ability to work. However, the res...

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

...her information please visit our website at www.biomsmedical.com. This press release may contain forward-looking statements, which reflect the current expectation of Lilly and BioMS regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results...

Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms

...and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Facto...

Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.

... to time with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-KSB, Quarterly Reports on Form 10-QSB and any current Reports on Form 8-K filed by the Company. Contact: General Media Inquiries Kristin O'Neill 312-233-1295 Kristin.Oneill@ede...

Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture

...now, all regular body washes caused dry skin damage. Now, Dove has discovered how to restore skin's natural moisture while cleansing with body wash. current body washes actually damage proteins and lipids in the skin's outer layer, often leading to the loss of critical moisture. Recognizing skin lipids req...

NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study

... in support of regulatory approval; and the tolerability profile and/or benefits of its product candidates. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to; positive results in clin...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

...D. Director of the Human and Molecular Genetics Center at the Medical College of Wisconsin. "This study demonstrates that ZFN technology bypasses the current need to conduct cumbersome experiments involving nuclear transfer (cloning) or embryonic stem cells and allows rapid creation of new animal models." ...

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

...mpanies to speed innovation to patients. Nearly 20 current FIPNet partners are located in proximity to the ne...worldwide, with more than 800,000 deaths annually. current medical techniques for the treatment of gastric ca... of $44.6 billion in economic output. The current proposed "Pathways to Biosimilars Act" now before ...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

...ough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other u...

Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results

...d cause Cardica's results to differ materially from those indicated by these forward-looking statements, including, without limitation, that Cardica's current and any future products may never gain any significant degree of market acceptance, that any future Cardica products face regulatory, reimbursement an...

Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing

... key personnel; changes in technology, government regulation and general market conditions; and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K for the year ended De...
Other Tags
(Date:10/17/2014)... have shown for the first time how bacteria can ... giving them the opportunity to get tremendous insights into ... study also discovered the bacterial growth in chronic lung ... slowed down by the immune cells. The researchers discovered ... "suffocate" the bacteria, forcing the bacteria to switch to ...
(Date:10/16/2014)... at William and Mary,s Virginia Institute of Marine ... the Environmental Protection Agency to identify the streams ... to develop tools to help local governments and ... depends critically on a dataset of tidal-marsh observations ... Only with this historical baseline can today,s researchers ...
(Date:10/16/2014)... are anything but sustainable: environmental damage to soil ... increasingly evident. Despite their disadvantages, however, monocultures remain ... the sole possibility of achieving higher yields in ... an ecology professor at the University of Zurich, ... forestry. After all, a new study carried out ...
Breaking Biology News(10 mins):Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3
(Date:10/20/2014)... October 20, 2014 Houston plastic surgeon ... the key elements of his innovative True Form ... plastic surgery residents and faculty at The University ... he, too, was once a medical student. Patronella, who ... private cosmetic plastic surgery practices in Texas, The ...
(Date:10/19/2014)... Hastings and Hastings, a Phoenix personal injury law ... greater Phoenix area and across Arizona reports record demand ... automobile accidents. Statistics have indicated a steady increase in ... such, Hastings and Hastings has seen a steady increase ... have been injured through no fault of their own ...
(Date:10/19/2014)... 2014 Recently, BambooIndustry.com, one of the ... new range of bamboo deckings . Moreover, the ... items; they are now available at deeply discounted rates. ... is hard to overstate the significance of online business ... online services. The company’s workers are striving to deliver ...
(Date:10/19/2014)... Texas (PRWEB) October 20, 2014 ... development for Partial Seizure, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ... featured news and press releases. It also reviews ... Partial Seizure and special features on late-stage and ...
(Date:10/19/2014)... 20, 2014 Recently, Top10BestSEOHosting.com has ... that JustHost, GoDaddy and HostMonster are the best ... (Virtual Private Server) is the method of partitioning ... of which has the appearance and capabilities of ... why the site pays close attention to VPS ...
Breaking Medicine News(10 mins):Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2
Other Contents